Integrated clinical operations, safety, data, and technology supporting complex oncology programs worldwide.
Sitero is an oncology-focused CRO partner for sponsors who need confident execution across complex protocols, global sites, and tight timelines. We combine full-service clinical trial delivery with an integrated technology ecosystem to reduce operational friction and keep studies on track.
Indications We Support
Sitero supports oncology programs across a broad range of solid tumors, hematologic malignancies, and treatment modalities. Our teams have experience in:
Solid tumors including breast, colorectal, lung (NSCLC), prostate, renal cell, hepatocellular, and head and neck cancers. Hematologic malignancies including lymphoma, leukemia, and multiple myeloma. Immuno-oncology programs including checkpoint inhibitors, bispecifics, and combination regimens. Cell and gene therapy applications in oncology including CAR-T and other adoptive cell therapies. Advanced trial designs including basket trials, umbrella trials, adaptive platforms, and dose-escalation studies.
Our clinical operations, biometrics, and drug safety teams bring direct experience in these indications, supported by the Mentor eClinical platform configured for complex oncology data capture, randomization, and reporting workflows.
Connected technology for oncology trial execution
Oncology studies generate more data, across more sources, with more frequent protocol changes than most other therapeutic areas. When your eClinical systems are stitched together from separate vendors, every change introduces delay and data reconciliation risk. Sitero delivers oncology trials on Mentor, the proprietary eClinical platform we built and own.
Clinical Trial Technology that Supports Execution
Sitero’s delivery model is supported by a broad eClinical ecosystem, including:
Mentor EDC
Integration advantageWhen your protocol adds a new cohort, the EDC build updates are handled by the same team running your study, not a third-party vendor with a separate change order.
Mentor RTSM
Integration advantageRTSM and EDC share a data layer. Stratification factors are verified at the point of entry rather than reconciled after the fact.
Mentor Site and Participant Payments
Integration advantagePayment triggers are driven from the same Mentor data your sites already enter, reducing manual reconciliation between visit completions, EDC data, and finance systems.
Mentor eConsent
Integration advantageYour Sitero project team and your sponsor team see the same data, in real time, without waiting for data transfers between systems.
Mentor CTMS and eTMF
Integration advantageYour Sitero project team and your sponsor team see the same data, in real time, without waiting for data transfers between systems.
Mentor Insights and Reporting
Integration advantageYour Sitero project team and your sponsor team see the same data, in real time, without waiting for data transfers between systems.
Oncology CRO services for complex clinical trials
Full-service clinical operations
Run your oncology study with consistent ownership from start-up through execution:
Oncology patient recruitment requires close collaboration with experienced investigators and high-performing research sites. Sitero works with oncology-focused clinical sites and academic centers to support efficient study startup, targeted patient recruitment strategies, and sustained site engagement throughout the trial lifecycle.
Biometrics: Data Management and Biostatistics
Support clean, analysis-ready data for complex oncology endpoints:
Many modern oncology trials rely on genomic profiling and biomarker-driven patient selection. Sitero supports precision oncology programs through biomarker data integration, coordination with central laboratories, and management of complex eligibility criteria.
IRB and Committee Operations
Reduce administrative drag and maintain governance:
Drug Safety and Pharmacovigilance Support
Maintain safety visibility and regulatory readiness:
Oncology therapies often involve complex safety monitoring requirements and accelerated regulatory pathways. Sitero supports oncology sponsors with pharmacovigilance programs designed to maintain regulatory readiness while ensuring continuous safety oversight.
Biosafety and IBC Services
Support studies requiring biosafety rigor and coordination:
Sitero Key Metrics
Integrated Workflows to Reduce Site Burden
For sponsors seeking simpler site execution, Sitero can align workflows across eConsent, EDC, and RTSM to reduce manual steps and improve coordination.
Global Oncology Trial Experience
Sitero supports oncology studies across a broad international footprint, helping sponsors manage global execution with consistent oversight and deliver across diverse indications, including immuno-oncology therapies and colorectal cancer clinical trials.
Why Sponsors Choose Sitero for Oncology Trials
Sponsors typically select Sitero when they need:
A partner that can cover operational execution plus enabling systems
Clear ownership and predictable delivery for lean sponsor teams
Broad functional capabilities beyond a single product or point solution
Global support without unnecessary complexity
FAQs
Yes. Sitero combines full-service delivery with an integrated eClinical technology ecosystem (EDC, RTSM/IRT, eConsent/eCOA, CTMS/eTMF, payments, and reporting).
Yes. Sitero supports PV and safety operations including case management, aggregate reporting, safety submissions, and signal detection/management.
Yes. Oncology programs with higher protocol complexity benefit from a model that aligns operational execution and oversight from the start.
Look for proven oncology experience, global execution capability, and an operating model that reduces handoffs across clinical operations, safety, governance, and data.
